← Back to Search

Behavioral Intervention

START Intervention for Attention Deficit Hyperactivity Disorder (ADHD) (START Trial)

N/A

Recruiting

Research Sponsored by Ann & Robert H Lurie Children's Hospital of Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

The child is between 6 and 12 years old

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 month

Awards & highlights

START Trial Summary

This trial aims to test if a program called START can increase access to treatment for ADHD and improve functioning for children and families. Participants will undergo a psychiatric evaluation before being assigned to either the START program or

Who is the study for?

This trial is for children aged 6-12 with a new or previously untreated ADHD diagnosis, confirmed by the study's psychiatrist. They must be able to understand and follow the study in English. Children treated for other conditions can join if it wasn't for ADHD.Check my eligibility

What is being tested?

The START program aims to improve access to ADHD treatment and family functioning. It involves six sessions covering various modules, delivered by trained individuals. The effectiveness will be compared against controls who receive only an informational pamphlet.See study design

What are the potential side effects?

Since START is a non-medical intervention involving educational modules, no direct medical side effects are expected from participation in this program.

START Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My child is between 6 and 12 years old.

START Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 month

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Attention-deficit/hyperactivity disorder (ADHD) Symptoms and Functioning

Attention-deficit/hyperactivity disorder (ADHD) Treatment Utilization

Secondary outcome measures

ADHD School Services

ADHD Stages of Engagement Questionnaire

Attention-deficit/hyperactivity disorder (ADHD) Knowledge

+9 more

START Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: START InterventionExperimental Treatment1 Intervention

Participants in the experimental group will be part of a 6-module weekly intervention where they will learn more about ADHD and its treatment.

Group II: Educational BrochureActive Control1 Intervention

Participants in the control group will receive an educational brochure by Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD).

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Ann & Robert H Lurie Children's Hospital of ChicagoLead Sponsor

258 Previous Clinical Trials

5,189,024 Total Patients Enrolled

1 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)

270 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are currently enrolled as participants in this clinical trial?

"Indeed, as per data on clinicaltrials.gov, this trial is actively seeking participants. The trial was first listed on July 1st, 2023 and last updated on February 26th, 2024. It aims to enroll a total of 106 patients from a single site."

Answered by AI

Are there any available openings for patients to participate in this study?

"Indeed, data available on clinicaltrials.gov indicates that this investigation is actively seeking volunteers. Initially shared on July 1st, 2023, the study has been recently updated on February 26th, 2024. A total of 106 individuals are sought from a single designated site for participation in this research endeavor."

Answered by AI

What are the eligibility criteria for individuals who can participate in this medical research study?

"This trial aims to recruit 106 individuals aged between 6 and 12 years old diagnosed with attention deficit hyperactivity disorder (ADHD). Eligible participants must meet the subsequent criteria: The child is aged from 6 to 12, has a confirmed ADHD diagnosis following assessment by an expert child psychiatrist within the study team, Either newly diagnosed or untreated for at least the past year post-diagnosis, Able to comprehend and complete informed consent in English. Children treated solely for psychiatric conditions other than ADHD may also be considered upon verification by the study's psychiatrist during enrollment."

Answered by AI

Could individuals aged 40 and above be considered suitable candidates for this research project?

"In this research project, individuals aged between 6 and 12 are eligible to participate. Notably, there are a total of 114 clinical trials focused on patients under the age of 18, while specifically for those over 65 years old, there are currently 34 available studies."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Testing "SupporT for ADHD and Related Treatment" (START) for Families of Children With ADHD

Andrea Spencer 2023. "Testing "SupporT for ADHD and Related Treatment" (START) for Families of Children With ADHD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05796427.

All > Adhd